Literature DB >> 30610950

Understanding structure-activity relationships of pH-sensitive cationic lipids facilitates the rational identification of promising lipid nanoparticles for delivering siRNAs in vivo.

Yusuke Sato1, Kazuki Hashiba2, Kosuke Sasaki2, Masatoshi Maeki3, Manabu Tokeshi3, Hideyoshi Harashima4.   

Abstract

Lipid nanoparticles (LNPs) are one of the more promising technologies for efficiently delivering short interfering RNA (siRNA) in vivo. A pH-sensitive cationic lipid that facilitates the targeting of hepatocytes and endosomal escape, strongly influences the availability of siRNA, thus making it a key material for efficient siRNA delivery. A systematic knowledge regarding lipid structure-activity relationships would greatly facilitate the development of sophisticated pH-sensitive cationic lipids for use in siRNA-based therapeutics. The systemic derivatization of a hydrophilic head group and hydrophobic tails of YSK12-C4, a pH-sensitive cationic lipid that was developed in our laboratory, revealed that hydrophilic head significantly affected the apparent pKa of the final product, a key factor in both intrahepatic distribution and endosomal escape. The clogP value of a hydrophilic head group was found to be associated with the apparent pKa of the product. In contrast, the hydrophobic tail structure strongly affected intrahepatic distribution without depending on apparent pKa. A structure-activity relationship study enabled the selection of an adequate combination of a hydrophilic head group and hydrophobic tails and permitted a potent LNP composed of a pH-sensitive cationic lipid CL4H6 (CL4H6-LNPs) to be developed that showed efficient gene silencing activity (50% effective dose: 0.0025 mg/kg), biodegradability and was tolerated. In vivo experiments revealed that the CL4H6-LNPs showed a superior efficiency for endosomal escape, cytosolic release and the RNA-induced silencing for the complex-loading of siRNAs compared to the previously developed LNPs.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Delivery; Endosomal escape; Hepatocytes; Lipid nanoparticles; Structure-activity relationship; pH-sensitive cationic lipid; siRNA

Mesh:

Substances:

Year:  2019        PMID: 30610950     DOI: 10.1016/j.jconrel.2019.01.001

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  24 in total

1.  Formulation and Delivery Technologies for mRNA Vaccines.

Authors:  Chunxi Zeng; Chengxiang Zhang; Patrick G Walker; Yizhou Dong
Journal:  Curr Top Microbiol Immunol       Date:  2020-06-02       Impact factor: 4.291

Review 2.  Nanotechnology for Enhanced Cytoplasmic and Organelle Delivery of Bioactive Molecules to Immune Cells.

Authors:  Xiaoyu Li; Charos Omonova Tuychi Qizi; Amari Mohamed Khamis; Can Zhang; Zhigui Su
Journal:  Pharm Res       Date:  2022-06-03       Impact factor: 4.200

3.  Cell Subtypes Within the Liver Microenvironment Differentially Interact with Lipid Nanoparticles.

Authors:  Cory D Sago; Brandon R Krupczak; Melissa P Lokugamage; Zubao Gan; James E Dahlman
Journal:  Cell Mol Bioeng       Date:  2019-05-08       Impact factor: 2.321

Review 4.  Methodical Design of Viral Vaccines Based on Avant-Garde Nanocarriers: A Multi-Domain Narrative Review.

Authors:  Ehsan Raoufi; Bahar Bahramimeimandi; M Salehi-Shadkami; Patcharida Chaosri; M R Mozafari
Journal:  Biomedicines       Date:  2021-05-06

Review 5.  Recent Advances in Stimulus-Responsive Nanocarriers for Gene Therapy.

Authors:  Cheng Yu; Long Li; Pei Hu; Yan Yang; Wei Wei; Xin Deng; Lu Wang; Franklin R Tay; Jingzhi Ma
Journal:  Adv Sci (Weinh)       Date:  2021-05-16       Impact factor: 16.806

Review 6.  RNA Nanotechnology-Mediated Cancer Immunotherapy.

Authors:  Yao-Xin Lin; Yi Wang; Sara Blake; Mian Yu; Lin Mei; Hao Wang; Jinjun Shi
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

Review 7.  Lipid-Nucleic Acid Complexes: Physicochemical Aspects and Prospects for Cancer Treatment.

Authors:  Ricardo Gaspar; Filipe Coelho; Bruno F B Silva
Journal:  Molecules       Date:  2020-10-28       Impact factor: 4.411

Review 8.  Evolution of drug delivery system from viewpoint of controlled intracellular trafficking and selective tissue targeting toward future nanomedicine.

Authors:  Yuma Yamada; Yusuke Sato; Takashi Nakamura; Hideyoshi Harashima
Journal:  J Control Release       Date:  2020-09-08       Impact factor: 9.776

Review 9.  Recent advances in siRNA delivery mediated by lipid-based nanoparticles.

Authors:  Sei Yonezawa; Hiroyuki Koide; Tomohiro Asai
Journal:  Adv Drug Deliv Rev       Date:  2020-08-06       Impact factor: 15.470

10.  Transport Oligonucleotides-A Novel System for Intracellular Delivery of Antisense Therapeutics.

Authors:  Oleg V Markov; Anton V Filatov; Maxim S Kupryushkin; Ivan V Chernikov; Olga A Patutina; Anton A Strunov; Elena L Chernolovskaya; Valentin V Vlassov; Dmitrii V Pyshnyi; Marina A Zenkova
Journal:  Molecules       Date:  2020-08-11       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.